ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Immunotherapy closing in on a cure for cancer – WGRZ-TV

Continue reading

2017-12-18 Michael Zand NEWS

Meet the Company that Mastered Upscaling Gene Therapy Vectors – Labiotech.eu (blog)

Meet the Company that Mastered Upscaling Gene Therapy VectorsLabiotech.eu (blog)Developing biopharmaceutical, and especially cell-based products, on an industrial scale, has long been a challenge in the life sciences industry. Cevec is a German company… Continue reading

2017-12-18 Michael Zand NEWS

British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease – Labiotech.eu (blog)

Labiotech.eu (blog)British Biotech Takes Over Development of Gene Therapy for Rare Immune DiseaseLabiotech.eu (blog)Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease (X-CGD) from the n… Continue reading

2017-12-18 Michael Zand NEWS

Poseida Therapeutics Announces First Patient Treated in Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory … – Markets Insider

Poseida Therapeutics Announces First Patient Treated in Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory …Markets InsiderSAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-… Continue reading

2017-12-18 Michael Zand NEWS

Poseida Therapeutics Announces First Patient Treated in Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory … – GlobeNewswire (press release)

Poseida Therapeutics Announces First Patient Treated in Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory …GlobeNewswire (press release)SAN DIEGO, Dec. 18, 2017 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company tra… Continue reading

2017-12-18 Michael Zand NEWS

CRISPR biotech Intellia promotes R&D head to CEO post – FierceBiotech

FierceBiotechCRISPR biotech Intellia promotes R&D head to CEO postFierceBiotech“After nearly four years of building Intellia and this exceptional team, the company is now poised to begin development of CRISPR/Cas9-based therapies,” explains Berming… Continue reading

2017-12-18 Michael Zand NEWS

CRISPR biotech Intellia promotes R&D head to CEO post – FierceBiotech

FierceBiotechCRISPR biotech Intellia promotes R&D head to CEO postFierceBiotech“After nearly four years of building Intellia and this exceptional team, the company is now poised to begin development of CRISPR/Cas9-based therapies,” explains Berming… Continue reading

2017-12-18 Michael Zand NEWS

First ever ‘off the shelf’ stem cell therapy nears European approval – pharmaphorum


WGRZ-TV

Immunotherapy closing in on a cure for cancer
WGRZ-TV
The immunotherapy trials are taking place in select cities across the United States, but people who live in Kentuckiana don’t have to travel far to get on the list. It’s happening right now at the James Graham Brown Cancer Center. James Long has spent …

Continue reading

2017-12-18 Michael Zand NEWS
  • 1
  • …
  • 773
  • 774
  • 775
  • 776
  • 777
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

PMLiVE

First ever ‘off the shelf’ stem cell therapy nears European approval
pharmaphorum
European regulators have recommended Alofisel, a new advanced therapy to treat complex perianal fistulas in patients with Crohn’s disease. The treatment is now just a step away from being the first ever allogeneic stem cell therapy approved in Europe …
CHMP backs Europe’s first allogeneic stem cell therapyPMLiVE
Belgian Biotech’s Crohn’s Disease Cell Therapy Gets Recommended for ApprovalLabiotech.eu (blog)
CHMP recommends EU approval of seven medicinesEuropean Biotechnology

all 6 news articles »